Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 10NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1Classical hematology 1

Conditions

Lymphoma 25Leukemia 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Follicular 16Breast Neoplasms 16Leukemia, Myeloid, Acute 15Lymphoma, Non-Hodgkin 14Lymphoma, Mantle-Cell 13Lymphoma, Large-Cell, Immunoblastic 13Burkitt Lymphoma 13Neoplasms, Plasma Cell 12Multiple Myeloma 12Leukemia, Lymphocytic, Chronic, B-Cell 12Lymphoma, B-Cell, Marginal Zone 10Leukemia, Myeloid, Chronic-Phase 10Neuroblastoma 9Myelodysplastic Syndromes 9Hodgkin Disease 9Congenital Abnormalities 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Accelerated Phase 8Myeloproliferative Disorders 7Central Nervous System Neoplasms 7Blast Crisis 7Waldenstrom Macroglobulinemia 6Primary Myelofibrosis 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Polycythemia Vera 5

Interventions

Cyclosporine 2fludarabine phosphate 1Stem Cell Transplantation 1Peripheral Blood Stem Cell Transplantation 1Methylprednisolone 1Methotrexate 1Cyclophosphamide 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 111-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Anemia, Aplastic × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00521430 2013-03-26

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

National Cancer Institute (NCI)

Phase NA Completed
30 enrolled
Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Neoplasms, Recurrence, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡